These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1414687)

  • 1. Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin.
    Tran A; Vanhée D; Capron A; Vorng H; Braquet P; Joseph M
    Agents Actions; 1992 May; 36(1-2):39-43. PubMed ID: 1414687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
    Adnot S; Joseph D; Vargaftig BB
    Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
    Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
    Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three paf-acether receptor antagonist ginkgolides.
    Korth R; Nunez D; Bidault J; Benveniste J
    Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
    Simon MF; Chap H; Braquet P; Douste-Blazy L
    Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
    Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
    Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesion by membrane-bound paf-acether.
    Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
    Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets.
    Korth R; Benveniste J
    Eur J Pharmacol; 1987 Oct; 142(3):331-41. PubMed ID: 3428349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
    Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
    Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.
    Bourgain RH; Maes L; Braquet P; Andries R; Touqui L; Braquet M
    Prostaglandins; 1985 Aug; 30(2):185-97. PubMed ID: 3931178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF-acether in AK-5 tumour cells.
    Marathe GK; Krishnakantha TP; D'Souza CJ
    Cell Biol Int Rep; 1991 Jan; 15(1):85-90. PubMed ID: 2004428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine potentiates human platelet aggregation induced by platelet-activating factor.
    Sipka S; Koltai M; Braquet P; Szegedi G
    Int Arch Allergy Immunol; 1992; 97(1):89-92. PubMed ID: 1582704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acether (PAF) in Ehrlich ascites tumour cells.
    Marathe GK; Krishnakanta TP; D'Souza CJ
    J Lipid Mediat; 1990; 2(5):257-62. PubMed ID: 2133270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
    Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
    Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
    Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L
    J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.